1-9 of 9
Diabetes and CKD: Strategies for Diagnosis and Treatment
Diabetes DiscourseDiabetes and CKD: Strategies for Diagnosis and Treatment
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ian de Boer, MD
Trimethylamine N-Oxide and CKD: A Concerning Link
Clinician's RoundtableTrimethylamine N-Oxide and CKD: A Concerning Link
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Clinician's RoundtableImproving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD
Improving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
Clinician's RoundtableImproving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
Ashley Baker, MSN, PMHNP
Chi D. Chu, MD, MAS
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Heart MattersAHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Javed Butler, MD
Chiadi Ndumele, M.D., Ph.D., M.H.S.
Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
Diabetes DiscourseRecapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
John Buse, MD, PhD
David Cherney, MD, PhD
- advertisement
The Latest on Patients with Hypertension & CKD
ASN Action CenterThe Latest on Patients with Hypertension & CKD
Jennifer Caudle, DO, FACOFP
Raymond Townsend, MD
Key Considerations on Catheter Based Renal Denervation in CKD
ASN Action CenterKey Considerations on Catheter Based Renal Denervation in CKD
Jennifer Caudle, DO, FACOFP
Raymond Townsend, MD
Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease
Diabetes DiscourseUnderstanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease
John Buse, MD, PhD
David Wheeler, MB, CHB, MD, FRCP